신경재활 시장 - 예측(2026-2031년)

The neurorehabilitation devices market, with a 12.07% CAGR, is expected to grow to USD 3.679 billion in 2031 from USD 1.857 billion in 2025.

The neurorehabilitation devices market is characterized by sustained growth, driven by a critical clinical imperative: enhancing functional recovery and quality of life for individuals with neurological impairments. This expansion is underpinned by a confluence of demographic shifts, technological innovation, and evolving care models. The rising global prevalence of neurological disorders-including stroke, spinal cord injury, Parkinson's disease, and multiple sclerosis-coupled with an ageing population, establishes a persistent and growing patient base requiring advanced rehabilitative care. Concurrently, technological breakthroughs are transforming therapeutic paradigms, moving beyond supportive aids to become active facilitators of neuroplasticity and recovery.

Primary Market Drivers and Technological Trends

Key drivers propelling the market forward are foundational and interrelated. The demographic trend of population ageing is a primary catalyst, as advanced age correlates with a higher incidence of chronic neurological conditions and neurodegenerative diseases. This creates sustained demand for devices that address motor deficits, cognitive decline, and the preservation of independence. Complementing this demand is the global expansion and specialization of healthcare infrastructure, particularly the establishment of dedicated rehabilitation centers. These facilities necessitate a diverse array of sophisticated equipment to deliver comprehensive, multidisciplinary care.

The most dynamic growth vector is technological convergence. The market is evolving through the integration of several advanced modalities:

• Robotics and Exoskeletons: Devices such as robotic gait trainers and upper-limb exoskeletons provide high-dosage, repetitive, and physiologically accurate movement therapy, reducing therapist burden and enabling intensive training.
• Brain-Computer Interfaces (BCIs): BCIs create direct communication pathways between the brain and external devices, offering promising avenues for restoring function and providing novel biofeedback mechanisms to engage neural circuits.
• Non-Invasive Neurostimulation: Techniques including transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) are used to modulate cortical excitability and promote neuroplasticity, often in conjunction with physical therapy.
• Wearable Sensors and Gamification: Wearables enable continuous monitoring of movement and progress outside clinical settings, while gamified rehabilitation systems improve patient engagement and adherence through interactive exercises.

A pivotal trend across these technologies is the integration of Artificial Intelligence (AI) and Data Analytics. AI algorithms can analyze vast datasets from device sensors to personalize therapy protocols in real-time, predict recovery trajectories, and provide clinicians with actionable insights. This shift towards data-driven, precision rehabilitation is enhancing treatment efficacy and optimizing therapeutic outcomes.

Market Segmentation and Competitive Landscape

The market is segmented by device type, end-user, and geography. Key product categories include neurorobotic systems, brain-computer interfaces, wearable devices, non-invasive stimulators, and neurorehabilitation gaming systems. End-users span hospitals, outpatient clinics, specialized rehabilitation centers, and a growing home-care segment, which emphasizes the need for devices that are user-friendly, portable, and suitable for remote monitoring and telehealth integration.

The competitive landscape features established medical technology leaders and specialized innovators. Major players like Abbott Laboratories leverage deep expertise in neuromodulation, offering implantable and external neurostimulators for conditions such as chronic pain and movement disorders. Specialized firms such as Bioness Inc. focus on wearable functional electrical stimulation (FES) systems for limb rehabilitation, while pioneers like Ekso Bionics Holdings, Inc. are at the forefront of robotic exoskeleton technology for gait training. These companies compete on clinical evidence, technological sophistication, integration capabilities, and success in navigating reimbursement pathways.

Geographical Outlook and Regional Dominance

North America maintains a dominant position in the global market. This leadership is attributed to several structural advantages: a mature and advanced healthcare infrastructure conducive to adopting high-cost technologies, a high prevalence of neurological disorders within a sizeable ageing population, and a regulatory and reimbursement environment that, while complex, has historically supported innovation in medical devices. Furthermore, the region's concentration of leading device manufacturers, research institutions, and venture capital fosters a robust ecosystem for development and commercialization.

Future Trajectory and Strategic Implications

The neurorehabilitation devices market is poised for continued evolution and growth. The irreversible demographic trends and increasing burden of neurological disorders ensure a durable addressable market. The future will be shaped by the deeper integration of AI, the proliferation of telerehabilitation platforms, and the development of more affordable, consumer-centric devices for home use. Success for industry participants will increasingly depend on demonstrating not only technical superiority but also clear value in improving functional outcomes, cost-effectiveness, and seamless integration into evolving care pathways. As the focus on long-term patient-centric outcomes intensifies, these devices will solidify their role as indispensable tools in the journey toward functional recovery, transforming neurorehabilitation into a more measurable, personalized, and accessible discipline.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Neurorehabilitation Devices Market Segmentation

• By Type
• Neurorobotic Systems
• Brain-Computer Interfaces
• Wearable Devices
• Non-Invasive Stimulators
• Neurorehabilitation Gaming Systems
• Others
• By Application
• Stroke
• Spinal Cord Injury
• Traumatic Brain Injury
• Parkinson's Disease
• Cerebral Palsy
• Others
• By End-User
• Hospitals
• Clinics
• Rehabilitation Centers
• Home Care Settings
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. NEUROREHABILITATION MARKET BY PRODUCT

• 5.1. Introduction
• 5.2. Neuro-Robotic System
• 5.3. Wearable Devices
• 5.4. Brain Computer Interface
• 5.5. Non-Invasive Stimulators
• 5.6. Neuronal Prosthetics
• 5.7. Others

6. NEUROREHABILITATION MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Stroke
• 6.3. Traumatic Brain Injury (TBI)
• 6.4. Spinal Cord Injury (SCI)
• 6.5. Parkinson's Disease
• 6.6. Cerebral Palsy
• 6.7. Others

7. NEUROREHABILITATION MARKET BY END-USER

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Clinics
• 7.4. Rehabilitation Centers
• 7.5. Home Care Settings

8. NEUROREHABILITATION MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Medtronic plc
• 10.2. Abbott Laboratories
• 10.3. Bionik Laboratories Corp.
• 10.4. Ekso Bionics Holdings, Inc.
• 10.5. DIH Medical Group
• 10.6. ReWalk Robotics
• 10.7. BioXtreme Ltd.
• 10.8. Kinova
• 10.9. Saebo Inc.

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations